Roquefort Therapeutics (ROQ)

Sector:

Alternative Investment Instruments

 7.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 9.00
  • 52 Week Low: 6.00
  • Currency: UK Pounds
  • Shares Issued: 129.15m
  • Volume: 53,920
  • Market Cap: £9.04m
  • Beta: 0.17

ROQ Overview

We established Roquefort Therapeutics plc to acquire businesses focused on early-stage opportunities in the medical biotechnology sector with the aim of generating optimal returns for both the target businesses and our shareholders. The investment strategy of the Company is to provide Shareholders with an attractive total return achieved primarily through capital appreciation. The Directors believe that there are numerous investment opportunities within both private and public businesses in the medical biotech sector in the United Kingdom, Continental Europe and Australia.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 1.3  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

ROQ Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 n/a (0.92) (3.71)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (1.63) (1.56)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

ROQ Company Announcements

Change of Auditor 24-Nov-2023 07:00 RNS
Significant Mesodermal Killer Cell Milestone 06-Nov-2023 07:00 RNS
Interim Results to 30 June 2023 27-Sep-2023 07:00 RNS

ROQ ShareCast News

No recent information was found.

Latest ROQ Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

ROQ Market Data

Currency UK Pounds
Share Price 7.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 9.00
52 Week Low 6.00
Volume 53,920
Shares Issued 129.15m
Market Cap £9.04m
Beta 0.17

ROQ Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
19.01% below the market average19.01% below the market average19.01% below the market average19.01% below the market average19.01% below the market average
22.03% above the sector average22.03% above the sector average22.03% above the sector average22.03% above the sector average22.03% above the sector average
Price Trend
15.48% above the market average15.48% above the market average15.48% above the market average15.48% above the market average15.48% above the market average
28.77% above the sector average28.77% above the sector average28.77% above the sector average28.77% above the sector average28.77% above the sector average
Income Not Available
Growth Not Available

ROQ Dividends

No dividends found

Trades for 08-Dec-2023

Time Volume / Share Price
14:00 26,557 @ 7.40p
13:58 27,363 @ 7.20p

Top of Page